Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
2025 Was Another Exceptionally Hot Year - 2IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- 3‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more
- 4Poll: 62% of Americans would oppose U.S. military action in Greenland
- 5Tech for Wellbeing: Applications and Devices for a Better You
- How will the universe end?
- Clocks to go forward one hour in Europe as summer time starts
- Putin says Russian forces will seize capital of Zaporizhzhya
- 6 Famous Cell phone Brands All over The Planet
- NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says
- Independence from the rat race for Recent college grads: Systems and Tips
- 1st-ever disease gene fix, Alzheimer's blood test: 7 medical breakthroughs in 2025
- Record-breaking 'space laser' erupts from merging galaxies 8 billion light-years away
- Well known SUVs With Low Energy Utilization In 2024
